Unknown OBSERVATIONAL NCT04734470

Expression of CD19 Complex in Lymphoproliferative Disorders (CD19)

Sponsor: Assiut University

Conditions Lymphoproliferative Disorders

Updated 4 times since 2021 Last updated: Feb 2, 2021 Started: Mar 31, 2021 Primary completion: Mar 31, 2023 Completion: Apr 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04734470, this observational or N/A phase trial focuses on Lymphoproliferative Disorders and remains ongoing. Sponsored by Assiut University, it has been updated 4 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
May 2023 — Jul 2024 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Mar 2021 — May 2023 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.